Progress in Neurotherapeutics and Neuropsychopharmacology

As this article doesn't contain an abstract, the image below is necessary to enable the article to be indexed by certain search engines. The resolution of the full-text PDF is much higher than that shown here.


Review Article

Rivastigmine in the Treatment of Dementia Associated with Parkinson's Disease: A Randomized, Double-blind, Placebo-controlled Study


Sibel Tekin a1c1 and Roger Lane a1
a1 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA; Email: sibel.tekin@novartis.com; roger.lane@novartis.com

Article author query
tekin s   [PubMed][Google Scholar] 
lane r   [PubMed][Google Scholar] 

Key Words: Parkinson's disease; clinical trial; rivastigmine; executive function; cholinesterase inhibitor; dementia.

Correspondence:
c1 Correspondence should be addressed to: Sibel Tekin, MD, Novartis Pharmaceuticals Corporation, One Health Plaza 59 Route 10, East Hanover NJ 07936, USA; Ph: +862 778 4242; Fax: +973 781 6550; Email: sibel.tekin@novartis.com.